Ginsenoside Rh3 - CAS# 105558-26-7 0 Racemate Multiple myeloma (MM) lines

Multiple myeloma (MM) lines

whereas both PI3Kα and -β were relatively unaffected (IC50 values>1 μM)

MX69 shows minimal inhibitory effect on normal human hematopoiesis in vitro and is very well tolerated in animal models

but absent in ovarian tissue)

Smiles: CC1(C)[C@@H]2[C@H](C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)/C(/C)=C/CC=C(C)C)[C@@]2(C)CC[C@@H]1O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O

Ginsenoside Rh3 - CAS# 105558-26-7 0 Racemate Multiple myeloma (MM) linesGinsenoside Rh3 is a bacterial metabolite of Ginsenoside Rg5. Ginsenoside Rh3 treatment in human retinal cells induces Nrf2 activation. Product information CAS Number: 105558 26 7 Molecular Weight: 604. 86 Formula: C36H60O7 Chemical Name: (2R,3R,4S,5S,6R) 2 {[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR) 11 hydroxy 3a,3b,6,6,9a pentamethyl 1 [(2Z) 6 methylhepta 2,5 dien 2 yl] hexadecahydro 1H cyclopenta[a]phenanthren 7 yl]oxy} 6 (hydroxymethyl)oxane 3,4,5